Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT) View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-09-20

AUTHORS

Malinda Lin, Karen Epport, Colleen Azen, Robertson Parkman, Donald B. Kohn, Ami J. Shah

ABSTRACT

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only cure for patients with severe combined immunodeficiency (SCID). The purpose of this study was to evaluate long-term neurodevelopment of patients with SCID following myeloablative chemotherapy and HSCT. MATERIALS AND METHODS: Sixteen pediatric patients diagnosed with SCID were tested using the Bayley Scales of Infant Development and the validated Vineland Adaptive Behavior Scales (VABS) pre- and 1-year post-HSCT. Three years post-HSCT, there were 11 patients available for testing and four patients available 5 years post-HSCT. Patients greater than 3 years of age were administered the Wechsler Preschool and Primary Scale of Intelligence. Both raw scores and scaled scores were analyzed. RESULTS: There was a significant decrease 1 year post-HSCT in the Bayley Mental Developmental Index (MDI) [92.5 (pre) vs. 70.81 (1 year post), p < 0.0001] and the VABS [99.73 (pre) vs. 79.87 (1 year post), p = <0.0001]. There was a significant decrease over time in the MDI [95.00 (pre) vs. 72.64 (1 year post) vs. 71.82 (3 years post), p < 0.0001], but no significant change between 1 and 3 years post-HSCT. There was no change in the Bayley Psychomotor Development Scale (PDI) [82.4 (pre) vs. 84.8 (1 year post), p = 0.68]. The PDI scores decreased over time [86.29 (pre) vs. 86 (1 year post) vs. 74.14 (3 years post), p = 0.045]. Although there was a decrease in scaled scores, there was not a loss of skills. Analysis of raw scores showed that there was an increase in the raw test scores, which indicated that these children acquired developmental skills, but at a slower rate than normal infants and toddlers. Younger children had a more significant decrease in adaptive scores compared with older children. CONCLUSIONS: These findings may reflect the effects of the isolation and prolonged hospitalization that characterizes the immediate post-transplant period. Patients miss out on social interactions and learning opportunities that normally occur at their respective stages of development. These restrictions keep patients from acquiring developmentally appropriate cognitive skills as well as gross and fine motor developmental milestones. Longitudinal follow-up will be important to quantify acquisition of skills. More... »

PAGES

231-237

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10875-008-9250-z

DOI

http://dx.doi.org/10.1007/s10875-008-9250-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010985935

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18807155


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adaptation, Psychological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alemtuzumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Busulfan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child Development", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cognition", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myeloablative Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuropsychological Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Psychomotor Performance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severe Combined Immunodeficiency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lin", 
        "givenName": "Malinda", 
        "id": "sg:person.01225332150.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225332150.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "General Clinical Research Center, Children\u2019s Hospital Los Angeles, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.239546.f", 
          "name": [
            "General Clinical Research Center, Children\u2019s Hospital Los Angeles, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Epport", 
        "givenName": "Karen", 
        "id": "sg:person.0651454623.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651454623.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "General Clinical Research Center, Children\u2019s Hospital Los Angeles, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.239546.f", 
          "name": [
            "General Clinical Research Center, Children\u2019s Hospital Los Angeles, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Azen", 
        "givenName": "Colleen", 
        "id": "sg:person.0777624340.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777624340.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Saban Research Institute of Children\u2019s Hospital Los Angeles, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.239546.f", 
          "name": [
            "Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA", 
            "Division of Research Immunology/Bone Marrow Transplantation, Children\u2019s Hospital Los Angeles, 4650 Sunset Boulevard, MS #62, Los Angeles, CA 90027 USA", 
            "The Saban Research Institute of Children\u2019s Hospital Los Angeles, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parkman", 
        "givenName": "Robertson", 
        "id": "sg:person.0746357540.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746357540.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Saban Research Institute of Children\u2019s Hospital Los Angeles, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.239546.f", 
          "name": [
            "Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA", 
            "Division of Research Immunology/Bone Marrow Transplantation, Children\u2019s Hospital Los Angeles, 4650 Sunset Boulevard, MS #62, Los Angeles, CA 90027 USA", 
            "The Saban Research Institute of Children\u2019s Hospital Los Angeles, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kohn", 
        "givenName": "Donald B.", 
        "id": "sg:person.01231045607.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231045607.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Saban Research Institute of Children\u2019s Hospital Los Angeles, Los Angeles, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.239546.f", 
          "name": [
            "Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA", 
            "Division of Research Immunology/Bone Marrow Transplantation, Children\u2019s Hospital Los Angeles, 4650 Sunset Boulevard, MS #62, Los Angeles, CA 90027 USA", 
            "The Saban Research Institute of Children\u2019s Hospital Los Angeles, Los Angeles, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Ami J.", 
        "id": "sg:person.01020106446.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020106446.63"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1700699", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032801834", 
          "https://doi.org/10.1038/sj.bmt.1700699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002292691", 
          "https://doi.org/10.1038/sj.bmt.1701295"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-09-20", 
    "datePublishedReg": "2008-09-20", 
    "description": "BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only cure for patients with severe combined immunodeficiency (SCID). The purpose of this study was to evaluate long-term neurodevelopment of patients with SCID following myeloablative chemotherapy and HSCT.\nMATERIALS AND METHODS: Sixteen pediatric patients diagnosed with SCID were tested using the Bayley Scales of Infant Development and the validated Vineland Adaptive Behavior Scales (VABS) pre- and 1-year post-HSCT. Three years post-HSCT, there were 11 patients available for testing and four patients available 5 years post-HSCT. Patients greater than 3 years of age were administered the Wechsler Preschool and Primary Scale of Intelligence. Both raw scores and scaled scores were analyzed.\nRESULTS: There was a significant decrease 1 year post-HSCT in the Bayley Mental Developmental Index (MDI) [92.5 (pre) vs. 70.81 (1 year post), p < 0.0001] and the VABS [99.73 (pre) vs. 79.87 (1 year post), p = <0.0001]. There was a significant decrease over time in the MDI [95.00 (pre) vs. 72.64 (1 year post) vs. 71.82 (3 years post), p < 0.0001], but no significant change between 1 and 3 years post-HSCT. There was no change in the Bayley Psychomotor Development Scale (PDI) [82.4 (pre) vs. 84.8 (1 year post), p = 0.68]. The PDI scores decreased over time [86.29 (pre) vs. 86 (1 year post) vs. 74.14 (3 years post), p = 0.045]. Although there was a decrease in scaled scores, there was not a loss of skills. Analysis of raw scores showed that there was an increase in the raw test scores, which indicated that these children acquired developmental skills, but at a slower rate than normal infants and toddlers. Younger children had a more significant decrease in adaptive scores compared with older children.\nCONCLUSIONS: These findings may reflect the effects of the isolation and prolonged hospitalization that characterizes the immediate post-transplant period. Patients miss out on social interactions and learning opportunities that normally occur at their respective stages of development. These restrictions keep patients from acquiring developmentally appropriate cognitive skills as well as gross and fine motor developmental milestones. Longitudinal follow-up will be important to quantify acquisition of skills.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10875-008-9250-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2423964", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1092207", 
        "issn": [
          "0271-9142", 
          "1573-2592"
        ], 
        "name": "Journal of Clinical Immunology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "keywords": [
      "hematopoietic stem cell transplantation", 
      "Severe Combined Immune Deficiency", 
      "Mental Developmental Index", 
      "pediatric patients", 
      "Vineland Adaptive Behavior Scales", 
      "post-hematopoietic stem cell transplant", 
      "immediate post-transplant period", 
      "Bayley Mental Developmental Index", 
      "post-transplant period", 
      "long-term neurodevelopment", 
      "stem cell transplant", 
      "stem cell transplantation", 
      "significant decrease", 
      "motor developmental milestones", 
      "year post-HSCT", 
      "years of age", 
      "Combined Immune Deficiency", 
      "severe combined immunodeficiency", 
      "myeloablative chemotherapy", 
      "post-HSCT", 
      "prolonged hospitalization", 
      "cell transplant", 
      "cell transplantation", 
      "immune deficiency", 
      "PDI scores", 
      "normal infants", 
      "only cure", 
      "patients", 
      "combined immunodeficiency", 
      "Bayley Scales", 
      "neurocognitive function", 
      "Developmental Index", 
      "infant development", 
      "older children", 
      "developmental milestones", 
      "scores", 
      "young children", 
      "Adaptive Behavior Scales", 
      "children", 
      "Wechsler Preschool", 
      "developmental skills", 
      "significant changes", 
      "raw scores", 
      "Primary Scale", 
      "loss of skills", 
      "years", 
      "adaptive scores", 
      "Behavior Scale", 
      "hospitalization", 
      "chemotherapy", 
      "transplantation", 
      "transplant", 
      "immunodeficiency", 
      "infants", 
      "neurodevelopment", 
      "decrease", 
      "Development Scale", 
      "test scores", 
      "cure", 
      "age", 
      "respective stages", 
      "acquisition of skills", 
      "toddlers", 
      "raw test scores", 
      "slower rate", 
      "deficiency", 
      "changes", 
      "findings", 
      "index", 
      "period", 
      "skills", 
      "scale", 
      "development", 
      "testing", 
      "study", 
      "time", 
      "increase", 
      "rate", 
      "post", 
      "social interaction", 
      "loss", 
      "effect", 
      "preschool", 
      "restriction", 
      "stage", 
      "cognitive skills", 
      "purpose", 
      "milestones", 
      "function", 
      "isolation", 
      "analysis", 
      "acquisition", 
      "opportunities", 
      "method", 
      "appropriate cognitive skills", 
      "interaction", 
      "materials", 
      "intelligence", 
      "significant decrease 1 year post-HSCT", 
      "decrease 1 year post-HSCT", 
      "Bayley Psychomotor Development Scale", 
      "Psychomotor Development Scale", 
      "fine motor developmental milestones", 
      "Term Neurocognitive Function"
    ], 
    "name": "Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)", 
    "pagination": "231-237", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010985935"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10875-008-9250-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18807155"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10875-008-9250-z", 
      "https://app.dimensions.ai/details/publication/pub.1010985935"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_459.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10875-008-9250-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10875-008-9250-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10875-008-9250-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10875-008-9250-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10875-008-9250-z'


 

This table displays all metadata directly associated to this object as RDF triples.

294 TRIPLES      22 PREDICATES      151 URIs      141 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10875-008-9250-z schema:about N06a1151919b24491917377f6b3d3ceb4
2 N0f921bdd07324ad282f36139d8efcb88
3 N114d2d3eb65d4b89ae7c9efad084991f
4 N15adf41fb1de46bda81dcfbb969b2653
5 N19faa40311c244549b0d1d8007b4ace7
6 N493ce1fdee7f4c1799ab8aba1b183b6c
7 N52050d0f0a1644039fe3cebde870fc83
8 N5d06f213e5744e8ebb1661abd2253370
9 N724e6dfc3061402590a43fa4ab68d863
10 N79071d4d063e4060affa43688edad374
11 N92caed98d9664f1a9b016a204f2ee888
12 N9551c645e6b64525afe47a0b0a8cd689
13 Na02790671a1147498b37d4fff4e512d1
14 Na64beb42fd6c42d3b3821f2fe089a57a
15 Nb699be069e3d4a80a17d9ebaa4b70d21
16 Nc4118780615f44d7988e14f122f17ce1
17 Nca2b9499f2a5442ea291a24fd2d57272
18 Ndc69c514a30d4337abbd51dd03cb1185
19 Ne5e51a54930842fabc3a9f6df8064345
20 anzsrc-for:11
21 anzsrc-for:1107
22 schema:author N4c89fcef07ab4e4d8cd0900312f0d2d0
23 schema:citation sg:pub.10.1038/sj.bmt.1700699
24 sg:pub.10.1038/sj.bmt.1701295
25 schema:datePublished 2008-09-20
26 schema:datePublishedReg 2008-09-20
27 schema:description BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the only cure for patients with severe combined immunodeficiency (SCID). The purpose of this study was to evaluate long-term neurodevelopment of patients with SCID following myeloablative chemotherapy and HSCT. MATERIALS AND METHODS: Sixteen pediatric patients diagnosed with SCID were tested using the Bayley Scales of Infant Development and the validated Vineland Adaptive Behavior Scales (VABS) pre- and 1-year post-HSCT. Three years post-HSCT, there were 11 patients available for testing and four patients available 5 years post-HSCT. Patients greater than 3 years of age were administered the Wechsler Preschool and Primary Scale of Intelligence. Both raw scores and scaled scores were analyzed. RESULTS: There was a significant decrease 1 year post-HSCT in the Bayley Mental Developmental Index (MDI) [92.5 (pre) vs. 70.81 (1 year post), p < 0.0001] and the VABS [99.73 (pre) vs. 79.87 (1 year post), p = <0.0001]. There was a significant decrease over time in the MDI [95.00 (pre) vs. 72.64 (1 year post) vs. 71.82 (3 years post), p < 0.0001], but no significant change between 1 and 3 years post-HSCT. There was no change in the Bayley Psychomotor Development Scale (PDI) [82.4 (pre) vs. 84.8 (1 year post), p = 0.68]. The PDI scores decreased over time [86.29 (pre) vs. 86 (1 year post) vs. 74.14 (3 years post), p = 0.045]. Although there was a decrease in scaled scores, there was not a loss of skills. Analysis of raw scores showed that there was an increase in the raw test scores, which indicated that these children acquired developmental skills, but at a slower rate than normal infants and toddlers. Younger children had a more significant decrease in adaptive scores compared with older children. CONCLUSIONS: These findings may reflect the effects of the isolation and prolonged hospitalization that characterizes the immediate post-transplant period. Patients miss out on social interactions and learning opportunities that normally occur at their respective stages of development. These restrictions keep patients from acquiring developmentally appropriate cognitive skills as well as gross and fine motor developmental milestones. Longitudinal follow-up will be important to quantify acquisition of skills.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N0e0a0945e5264f8e874a82482b855981
32 N4a592aa6546f468c904a99cb9a5174a0
33 sg:journal.1092207
34 schema:keywords Adaptive Behavior Scales
35 Bayley Mental Developmental Index
36 Bayley Psychomotor Development Scale
37 Bayley Scales
38 Behavior Scale
39 Combined Immune Deficiency
40 Development Scale
41 Developmental Index
42 Mental Developmental Index
43 PDI scores
44 Primary Scale
45 Psychomotor Development Scale
46 Severe Combined Immune Deficiency
47 Term Neurocognitive Function
48 Vineland Adaptive Behavior Scales
49 Wechsler Preschool
50 acquisition
51 acquisition of skills
52 adaptive scores
53 age
54 analysis
55 appropriate cognitive skills
56 cell transplant
57 cell transplantation
58 changes
59 chemotherapy
60 children
61 cognitive skills
62 combined immunodeficiency
63 cure
64 decrease
65 decrease 1 year post-HSCT
66 deficiency
67 development
68 developmental milestones
69 developmental skills
70 effect
71 findings
72 fine motor developmental milestones
73 function
74 hematopoietic stem cell transplantation
75 hospitalization
76 immediate post-transplant period
77 immune deficiency
78 immunodeficiency
79 increase
80 index
81 infant development
82 infants
83 intelligence
84 interaction
85 isolation
86 long-term neurodevelopment
87 loss
88 loss of skills
89 materials
90 method
91 milestones
92 motor developmental milestones
93 myeloablative chemotherapy
94 neurocognitive function
95 neurodevelopment
96 normal infants
97 older children
98 only cure
99 opportunities
100 patients
101 pediatric patients
102 period
103 post
104 post-HSCT
105 post-hematopoietic stem cell transplant
106 post-transplant period
107 preschool
108 prolonged hospitalization
109 purpose
110 rate
111 raw scores
112 raw test scores
113 respective stages
114 restriction
115 scale
116 scores
117 severe combined immunodeficiency
118 significant changes
119 significant decrease
120 significant decrease 1 year post-HSCT
121 skills
122 slower rate
123 social interaction
124 stage
125 stem cell transplant
126 stem cell transplantation
127 study
128 test scores
129 testing
130 time
131 toddlers
132 transplant
133 transplantation
134 year post-HSCT
135 years
136 years of age
137 young children
138 schema:name Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)
139 schema:pagination 231-237
140 schema:productId N169a09caa8fe41548a8fe0ea051a3719
141 N90cff428c761436da6602278f1003ef8
142 Na4dbc6e57e7d4af7bdd924f0b0c695dd
143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010985935
144 https://doi.org/10.1007/s10875-008-9250-z
145 schema:sdDatePublished 2021-12-01T19:19
146 schema:sdLicense https://scigraph.springernature.com/explorer/license/
147 schema:sdPublisher N1de33b554f26406aa3f50eb530b7d82e
148 schema:url https://doi.org/10.1007/s10875-008-9250-z
149 sgo:license sg:explorer/license/
150 sgo:sdDataset articles
151 rdf:type schema:ScholarlyArticle
152 N06a1151919b24491917377f6b3d3ceb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Busulfan
154 rdf:type schema:DefinedTerm
155 N0e0a0945e5264f8e874a82482b855981 schema:volumeNumber 29
156 rdf:type schema:PublicationVolume
157 N0f921bdd07324ad282f36139d8efcb88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Severe Combined Immunodeficiency
159 rdf:type schema:DefinedTerm
160 N114d2d3eb65d4b89ae7c9efad084991f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Psychomotor Performance
162 rdf:type schema:DefinedTerm
163 N15adf41fb1de46bda81dcfbb969b2653 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Alemtuzumab
165 rdf:type schema:DefinedTerm
166 N169a09caa8fe41548a8fe0ea051a3719 schema:name dimensions_id
167 schema:value pub.1010985935
168 rdf:type schema:PropertyValue
169 N19faa40311c244549b0d1d8007b4ace7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Cognition
171 rdf:type schema:DefinedTerm
172 N1de33b554f26406aa3f50eb530b7d82e schema:name Springer Nature - SN SciGraph project
173 rdf:type schema:Organization
174 N1fc45b5919cd466b83c03165d3e4adea rdf:first sg:person.01231045607.82
175 rdf:rest N209bd0dcddde43e6b05dcbb3eec32aa4
176 N209bd0dcddde43e6b05dcbb3eec32aa4 rdf:first sg:person.01020106446.63
177 rdf:rest rdf:nil
178 N493ce1fdee7f4c1799ab8aba1b183b6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Hematopoietic Stem Cell Transplantation
180 rdf:type schema:DefinedTerm
181 N4a592aa6546f468c904a99cb9a5174a0 schema:issueNumber 2
182 rdf:type schema:PublicationIssue
183 N4c89fcef07ab4e4d8cd0900312f0d2d0 rdf:first sg:person.01225332150.48
184 rdf:rest N58eb123051f64c2daf4d5b9badaa9ca6
185 N52050d0f0a1644039fe3cebde870fc83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Adaptation, Psychological
187 rdf:type schema:DefinedTerm
188 N58eb123051f64c2daf4d5b9badaa9ca6 rdf:first sg:person.0651454623.78
189 rdf:rest Nf17253cb89df4db794296c0d08dd55b4
190 N5d06f213e5744e8ebb1661abd2253370 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Myeloablative Agonists
192 rdf:type schema:DefinedTerm
193 N724e6dfc3061402590a43fa4ab68d863 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Infant
195 rdf:type schema:DefinedTerm
196 N79071d4d063e4060affa43688edad374 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Antibodies, Monoclonal
198 rdf:type schema:DefinedTerm
199 N90cff428c761436da6602278f1003ef8 schema:name doi
200 schema:value 10.1007/s10875-008-9250-z
201 rdf:type schema:PropertyValue
202 N92caed98d9664f1a9b016a204f2ee888 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Child Development
204 rdf:type schema:DefinedTerm
205 N9551c645e6b64525afe47a0b0a8cd689 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Antibodies, Neoplasm
207 rdf:type schema:DefinedTerm
208 Na02790671a1147498b37d4fff4e512d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Follow-Up Studies
210 rdf:type schema:DefinedTerm
211 Na4dbc6e57e7d4af7bdd924f0b0c695dd schema:name pubmed_id
212 schema:value 18807155
213 rdf:type schema:PropertyValue
214 Na64beb42fd6c42d3b3821f2fe089a57a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Cyclophosphamide
216 rdf:type schema:DefinedTerm
217 Nb699be069e3d4a80a17d9ebaa4b70d21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Treatment Outcome
219 rdf:type schema:DefinedTerm
220 Nc4118780615f44d7988e14f122f17ce1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Neuropsychological Tests
222 rdf:type schema:DefinedTerm
223 Nca2b9499f2a5442ea291a24fd2d57272 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Antineoplastic Agents
225 rdf:type schema:DefinedTerm
226 Ndc69c514a30d4337abbd51dd03cb1185 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
227 schema:name Antibodies, Monoclonal, Humanized
228 rdf:type schema:DefinedTerm
229 Ndda09c5f85d947b89a746e61fd9b82e4 rdf:first sg:person.0746357540.51
230 rdf:rest N1fc45b5919cd466b83c03165d3e4adea
231 Ne5e51a54930842fabc3a9f6df8064345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
232 schema:name Humans
233 rdf:type schema:DefinedTerm
234 Nf17253cb89df4db794296c0d08dd55b4 rdf:first sg:person.0777624340.39
235 rdf:rest Ndda09c5f85d947b89a746e61fd9b82e4
236 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
237 schema:name Medical and Health Sciences
238 rdf:type schema:DefinedTerm
239 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
240 schema:name Immunology
241 rdf:type schema:DefinedTerm
242 sg:grant.2423964 http://pending.schema.org/fundedItem sg:pub.10.1007/s10875-008-9250-z
243 rdf:type schema:MonetaryGrant
244 sg:journal.1092207 schema:issn 0271-9142
245 1573-2592
246 schema:name Journal of Clinical Immunology
247 schema:publisher Springer Nature
248 rdf:type schema:Periodical
249 sg:person.01020106446.63 schema:affiliation grid-institutes:grid.239546.f
250 schema:familyName Shah
251 schema:givenName Ami J.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020106446.63
253 rdf:type schema:Person
254 sg:person.01225332150.48 schema:affiliation grid-institutes:grid.42505.36
255 schema:familyName Lin
256 schema:givenName Malinda
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225332150.48
258 rdf:type schema:Person
259 sg:person.01231045607.82 schema:affiliation grid-institutes:grid.239546.f
260 schema:familyName Kohn
261 schema:givenName Donald B.
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231045607.82
263 rdf:type schema:Person
264 sg:person.0651454623.78 schema:affiliation grid-institutes:grid.239546.f
265 schema:familyName Epport
266 schema:givenName Karen
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651454623.78
268 rdf:type schema:Person
269 sg:person.0746357540.51 schema:affiliation grid-institutes:grid.239546.f
270 schema:familyName Parkman
271 schema:givenName Robertson
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746357540.51
273 rdf:type schema:Person
274 sg:person.0777624340.39 schema:affiliation grid-institutes:grid.239546.f
275 schema:familyName Azen
276 schema:givenName Colleen
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777624340.39
278 rdf:type schema:Person
279 sg:pub.10.1038/sj.bmt.1700699 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032801834
280 https://doi.org/10.1038/sj.bmt.1700699
281 rdf:type schema:CreativeWork
282 sg:pub.10.1038/sj.bmt.1701295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002292691
283 https://doi.org/10.1038/sj.bmt.1701295
284 rdf:type schema:CreativeWork
285 grid-institutes:grid.239546.f schema:alternateName General Clinical Research Center, Children’s Hospital Los Angeles, Los Angeles, CA USA
286 The Saban Research Institute of Children’s Hospital Los Angeles, Los Angeles, CA USA
287 schema:name Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA
288 Division of Research Immunology/Bone Marrow Transplantation, Children’s Hospital Los Angeles, 4650 Sunset Boulevard, MS #62, Los Angeles, CA 90027 USA
289 General Clinical Research Center, Children’s Hospital Los Angeles, Los Angeles, CA USA
290 The Saban Research Institute of Children’s Hospital Los Angeles, Los Angeles, CA USA
291 rdf:type schema:Organization
292 grid-institutes:grid.42505.36 schema:alternateName Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA
293 schema:name Department of Pediatrics, Keck School of Medicine, Los Angeles, CA USA
294 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...